We are live on ! Find out more
UROV

Urovant Sciences Ltd.
UROV

Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Urovant Sciences Ltd. in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 41 → 0 (-41)

100% less capital invested

Capital invested by funds: $99.7M → $0 (-$99.7M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 41

Holders
–
Holders Change
-41
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
41
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$50.3M
2
BCM
Beryl Capital Management
California
-$5.67M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.51M
4
PCM
Prelude Capital Management
New York
-$3.99M
5
GF
Gabelli Funds
New York
-$3.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
– -$50.3M -3,116,831 Closed
BCM
2
Beryl Capital Management
California
– -$5.67M -351,579 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$5.51M -341,426 Closed
PCM
4
Prelude Capital Management
New York
– -$3.99M -247,148 Closed
GF
5
Gabelli Funds
New York
– -$3.89M -241,227 Closed
OCM
6
Orchard Capital Management
Illinois
– -$3.1M -191,933 Closed
CS
7
Candriam SCA
Luxembourg
– -$2.71M -167,787 Closed
GCL
8
Glazer Capital LLC
New York
– -$2.69M -167,060 Closed
GCIA
9
Gabelli & Co Investment Advisers
New York
– -$2.57M -159,135 Closed
KPF
10
K2 Principal Fund
Ontario, Canada
– -$2.36M -146,556 Closed
Walleye Capital
11
Walleye Capital
New York
– -$1.93K -119,700 Closed
Geode Capital Management
12
Geode Capital Management
Massachusetts
– -$1.61M -99,876 Closed
E
13
Ergoteles
New York
– -$1.58M -97,825 Closed
KC
14
Kellner Capital
New York
– -$1.45M -90,000 Closed
YCM
15
Yakira Capital Management
Connecticut
– -$1.29M -80,000 Closed
WCM
16
Wildcat Capital Management
New York
– -$1.05M -65,209 Closed
Bank of America
17
Bank of America
North Carolina
– -$1.03M -64,000 Closed
Northern Trust
18
Northern Trust
Illinois
– -$868K -53,828 Closed
MWNA
19
Marshall Wace North America
New York
– -$766K -47,523 Closed
SMC
20
S. Muoio & Co
New York
– -$765K -47,401 Closed
Skandinaviska Enskilda Banken (SEB)
21
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$745K -46,299 Closed
Two Sigma Investments
22
Two Sigma Investments
New York
– -$702K -43,551 Closed
LA
23
LVW Advisors
New York
– -$636K -39,451 Closed
Marshall Wace
24
Marshall Wace
United Kingdom
– -$556K -34,494 Closed
Qube Research & Technologies (QRT)
25
Qube Research & Technologies (QRT)
United Kingdom
– -$474K -29,400 Closed
1
2

UROV Hedge Fund Activity: Q1 2021 in Review

0 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q1 2021, worth a combined $0 — down 100% from $99.7M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of UROV and 0 opened new positions — a net loss of 41 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $50.3M sold.

  • 0 institutional investors held Urovant Sciences Ltd. (UROV) as of Q1 2021, down from 41 in Q4 2020.
  • Funds reported $0 of Urovant Sciences Ltd. stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Urovant Sciences Ltd. positions in Q1 2021 and 41 closed out, a net change of -41 holders.
  • The largest Urovant Sciences Ltd. seller in Q1 2021 was Perceptive Advisors, an estimated $50.3M sold.

Based on aggregated 13F filings for Q1 2021.